Exact Sciences (EXAS) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Exact Sciences (EXAS) PT Raised to $20 at Jefferies
July 27, 2016 8:38 AM EDTJefferies analyst Brandon Couillard reiterated a Buy rating and raised his price target on Exact Sciences (NASDAQ: EXAS) to $20.00 (from $13.00) following strong Q2 results.
Couillard commented, "EXAS delivered an exceptionally strong 2Q that exhibited positive progress on essentially every key... More
